SLS SELLAS Life Sciences Group, Inc.

Fundamentals / CIK 0001390478 / USD

SELLAS Life Sciences Group, Inc. reported $141.1M in total assets and a net loss of $35.76M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$11.85M$5.93M$0-$39.26MFY 2016 Net Income: -$17.68M2016FY 2017 Net Income: -$23.75M2017FY 2018 Net Income: -$27.67M2018FY 2019 Revenue: $0FY 2019 Net Income: -$19.29M2019FY 2020 Revenue: $1.90MFY 2020 Net Income: -$16.76M2020FY 2021 Revenue: $7.60MFY 2021 Net Income: -$20.70M2021FY 2022 Revenue: $1.00MFY 2022 Net Income: -$41.30M2022FY 2023 Revenue: $0FY 2023 Net Income: -$37.34M2023FY 2024 Net Income: -$30.88M2024FY 2025 Net Income: -$26.86M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $0 $1.00M $7.60M $1.90M $0 -- -- --
Cost of Revenue $0 $0 $0 $100K $200K $0 -- -- -- --
Gross Profit -- -- $0 $900K $7.40M $1.90M -- -- -- --
Research & Development $16.02M $19.10M $24.01M $20.27M $15.67M $9.28M $7.29M $8.77M $6.07M $11.39M
Selling, General & Admin $12.25M $12.42M $13.86M $12.58M $11.32M $9.60M $9.92M $12.77M $15.09M $4.59M
Total Operating Expenses -- -- -- -- -- -- -- -- -- $31.87M
Operating Income -$28.27M -$31.51M -$37.87M -$41.95M -$25.29M -$16.98M -$20.04M $0 -$23.04M -$15.99M
EBITDA -- -- -- -- -- -- -- -- -- -$15.98M
Income Before Tax -$26.86M -$30.88M -$37.34M -$41.30M -$20.94M -$16.77M -$19.37M -$29.05M -$23.50M -$17.68M
Income Tax Expense $0 $0 $0 $0 -$237K -$17K -$81K -$1.38M $253K $1.0K
Net Income -$26.86M -$30.88M -$37.34M -$41.30M -$20.70M -$16.76M -$19.29M -$27.67M -$23.75M -$17.68M
Basic EPS -$0.25 -$0.50 -$1.34 -$2.13 -$1.34 -$2.11 -$10.92 -$157.72 -$522.00 -$933.00
Diluted EPS -$0.25 -$0.50 -$1.34 -$2.13 -$1.34 -$2.11 -$10.92 -$157.72 -$522.00 -$933.00
Basic Shares Outstanding 109.1M 61.2M 27.8M 19.4M 15.5M 8.0M 2.6M 261.5K 46.8K 18.9K
Diluted Shares Outstanding 109.1M 61.2M 27.8M 19.4M 15.5M 8.0M 2.6M 261.5K 46.8K 18.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cost of Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $7.03M $6.27M $5.13M $4.73M $4.22M $3.87M $3.21M $4.44M
Selling, General & Admin -- -- -- $3.52M $2.87M $3.00M $2.86M $2.48M
Operating Income -$11.31M -$10.63M -$9.25M -$8.26M -$7.08M -$6.87M -$6.06M -$6.92M
Net Income -$10.09M -$9.61M -$8.41M -$7.66M -$6.79M -$6.60M -$5.81M -$6.74M
Basic EPS -$0.05 -$0.05 -$0.05 -- -$0.06 -$0.07 -$0.07 --
Diluted EPS -$0.05 -$0.05 -$0.05 -- -$0.06 -$0.07 -$0.07 --
Basic Shares Outstanding 202.4M 189.2M 172.5M -- 108.4M 98.6M 87.8M --
Diluted Shares Outstanding 202.4M 189.2M 172.5M -- 108.4M 98.6M 87.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $71.79M $13.89M $2.53M $17.12M $21.36M $35.30M $7.28M $5.34M $2.32M $5.96M
Cash & Short-Term Investments $71.79M $13.89M $2.53M $17.12M $21.36M $35.30M $7.28M $5.34M $2.32M $5.96M
Accounts Receivable, Net -- -- -- -- $0 -- -- -- -- --
Total Current Assets $75.21M $16.33M $3.17M $17.76M $23.04M $36.92M $8.24M $5.84M $13.09M $6.38M
Property, Plant & Equipment, Net -- -- -- -- -- -- -- -- -- $199K
Goodwill $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M $5.90M
Total Non-Current Assets $3.13M $3.10M $3.05M $3.19M $3.23M $9.12M $8.37M $11.08M $20.44M $41K
Total Assets $78.34M $19.43M $6.22M $20.94M $26.27M $46.05M $16.61M $16.91M $33.53M $6.42M
Accounts Payable $2.95M $3.50M $5.64M $3.36M $2.14M $4.66M $3.90M $3.75M $11.69M $840K
Short-Term Debt -- -- -- -- -- -- -- $0 $8.38M $16.40M
Deferred Revenue (Current) -- -- -- -- $0 $5.60M $0 -- -- --
Total Current Liabilities $7.02M $9.51M $13.73M $15.52M $4.98M $12.34M $5.29M $5.97M $24.57M $5.76M
Long-Term Debt -- -- -- -- -- -- -- $0 $2.61M --
Total Non-Current Liabilities $457K $457K $460K $577K $946K $5.75M $5.23M $5.70M $6.89M $5.66M
Total Liabilities $7.47M $9.97M $14.20M $16.09M $5.93M $18.09M $10.52M $11.67M $31.46M $11.42M
Total Debt (incl. Leases) $1.00M $1.00M $906K $945K $808K $991K $217K $0 $10.99M $16.40M
Common Stock $15K $7.0K $3.0K $2.0K $2.0K $1.0K $1.0K $1.0K $1.0K $2.0K
Retained Earnings -$275.0M -$248.1M -$217.2M -$179.9M -$138.6M -$117.9M -$101.1M -$81.86M -$54.19M -$30.43M
Total Stockholders' Equity $70.87M $9.46M -$7.98M $4.85M $20.35M $27.96M $6.09M $5.25M $2.07M -$5.00M
Total Equity $70.87M $9.46M -$7.98M $4.85M $20.35M $27.96M $6.09M $5.25M $2.07M -$5.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $134.7M $138.3M $107.1M $71.79M $44.32M $25.30M $28.40M $13.89M
Cash & Short-Term Investments $134.7M $138.3M $107.1M $71.79M $44.32M $25.30M $28.40M $13.89M
Total Current Assets $138.6M $142.5M $111.2M $75.21M $49.05M $29.45M $31.97M $16.33M
Goodwill $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M $1.91M
Total Non-Current Assets $2.52M $2.88M $3.01M $3.13M $2.50M $2.86M $2.98M $3.10M
Total Assets $141.1M $145.4M $114.2M $78.34M $51.55M $32.30M $34.96M $19.43M
Accounts Payable $2.09M $3.09M $3.63M $2.95M $2.31M $3.34M $3.76M $3.50M
Total Current Liabilities $9.29M $7.57M $6.46M $7.02M $5.92M $6.00M $6.89M $9.51M
Total Non-Current Liabilities $0 $157K $309K $457K $0 $157K $309K $457K
Total Liabilities $9.29M $7.73M $6.76M $7.47M $5.92M $6.16M $7.20M $9.97M
Total Debt (incl. Leases) $599K $737K $871K $1.00M $599K $737K $870K $1.00M
Common Stock $20K $20K $18K $15K $12K $10K $9.0K $7.0K
Retained Earnings -$303.1M -$293.0M -$283.4M -$275.0M -$267.3M -$260.5M -$253.9M -$248.1M
Total Stockholders' Equity $131.8M $137.7M $107.4M $70.87M $45.63M $26.15M $27.76M $9.46M
Total Equity $131.8M $137.7M $107.4M $70.87M $45.63M $26.15M $27.76M $9.46M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.86M -$30.88M -$37.34M -$41.30M -$20.70M -$16.76M -$19.29M -$27.67M -$23.75M -$17.68M
Depreciation & Amortization -- -- -- -- -- -- -- -- -- $3.0K
Stock-Based Compensation $1.96M $1.56M $2.09M $1.73M $1.01M $578K $573K $395K $3.17M $354K
Change in Payables -$535K -$2.14M $2.30M $1.21M -$2.51M -$836K $12K -$7.94M $8.37M -$757K
Operating Cash Flow -$28.39M -$35.40M -$31.41M -$23.81M -$26.02M -$10.42M -$17.64M -$30.42M -$10.99M -$11.85M
Capital Expenditure -- -- -- -- -- -- -- -- -- -$6.0K
Free Cash Flow -- -- -- -- -- -- -- -- -- -$11.86M
Investing Cash Flow -- $0 -$5.50M -$4.50M $0 -- -- $0 $12.16M -$85K
Common Stock Issued -- $0 $289K $1.05M $9.01M $29.60M $15.97M $21.56M $6.01M $33.53M
Dividends Paid -- -- -- -- -- -- $0 -$487K $0 --
Financing Cash Flow $86.30M $46.76M $22.32M $24.08M $12.07M $38.44M $19.57M $23.12M $5.53M $16.50M
Net Change in Cash $57.91M $11.36M -$14.60M -$4.23M -$13.95M $28.02M $1.93M -$7.30M $6.70M $4.57M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$10.09M -$9.61M -$8.41M -$7.66M -$6.79M -$6.60M -$5.81M -$6.74M
Stock-Based Compensation $1.93M $1.01M $798K $447K $503K $501K $505K $373K
Change in Payables -$997K -$547K $685K $660K -$1.03M -$441K $277K -$1.12M
Operating Cash Flow -$5.94M -$7.59M -$8.85M -$4.92M -$7.07M -$7.33M -$9.07M -$7.15M
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow $2.31M $38.83M $44.15M $32.39M $26.09M $4.23M $23.58M $8.0K
Net Change in Cash -$3.63M $31.25M $35.30M $27.47M $19.02M -$3.10M $14.51M -$7.14M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- 90.0% 97.4% 100.0% -- -- -- --
Operating Margin -- -- -- -4195.0% -332.8% -893.8% -- -- -- --
Net Profit Margin -- -- -- -4130.1% -272.4% -881.9% -- -- -- --
Return on Equity (ROE) -37.9% -326.3% -- -851.4% -101.7% -59.9% -316.6% -527.6% -1147.5% --
Return on Assets (ROA) -34.3% -158.9% -600.4% -197.2% -78.8% -36.4% -116.2% -163.6% -70.9% -275.4%
Current Ratio 10.72x 1.72x 0.23x 1.14x 4.63x 2.99x 1.56x 0.98x 0.53x 1.11x
Quick Ratio 10.23x 1.46x 0.18x 1.10x 4.29x 2.86x 1.38x 0.89x 0.09x 1.04x
Debt to Equity 0.01x 0.11x -- 0.19x 0.04x 0.04x 0.04x 0.00x 5.31x --
Revenue Growth (YoY) -- -- -100.0% -86.8% +300.0% -- -- -- -- --
Gross Profit Growth (YoY) -- -- -100.0% -87.8% +289.5% -- -- -- -- --
5Y Revenue / Share Growth -- -- -- -- -- -- -100.0% -- -- --
10Y Revenue / Share Growth -- -- -100.0% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -27.1% -23.6% -27.4% -37.9% -56.9% -100.4% -97.7% -326.3%
Return on Assets (ROA) -25.3% -22.3% -25.8% -34.3% -50.3% -81.3% -77.6% -158.9%
Current Ratio 14.92x 18.83x 17.22x 10.72x 8.28x 4.91x 4.64x 1.72x
Quick Ratio 14.51x 18.28x 16.59x 10.23x 7.48x 4.22x 4.12x 1.46x
Debt to Equity 0.00x 0.01x 0.01x 0.01x 0.01x 0.03x 0.03x 0.11x
Source: SEC EDGAR CompanyFacts (CIK 0001390478) · from June 30, 2010 Data through September 30, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal